Characteristic
*Linear regression models testing association of GRS with baseline log-transformed biomarker levels, adjusted by Clinical center networks and source of genetic data (ACCSET or ANYSET). **Linear regression models testing association of GRS with 12-month log-transformed biomarker levels, adjusted by blood pressure and Lipid trial assignments, Clinical center networks and source of genetic data (ACCSET or ANYSET). § Linear regression models testing association of GRS with change in log-transformed biomarker levels from baseline to 12-months, adjusted by blood pressure and Lipid trial assignments, Clinical center networks and source of genetic data (ACCSET or ANYSET). ‡Significant at p<0.0005 (Bonferroni adjusted). *Fold change of GLP-1 levels obtained from generalized linear regression models for association of rs57922 risk allele (T) with change in 12-month GLP-1 levels from baseline. Covariates included sub-trials, clinical center networks, source of genetic data, baseline HbA1c, prior CVD, diabetes duration and smoking. The 61y cut-off for categorization was the median age of subjects in the intensive arm. 
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